Here’s whether Pfizer Inc. (PFE) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.34% over 10 days); 3-month momentum positive (+5.8%). Concerns: RSI 75 — overbought, elevated pullback risk. Currently 6.8% off its 52-week high. Score: +4/7.
PFE is in a confirmed uptrend, trading above both its 50-day ($25.17) and 200-day ($25.91) moving averages. With an RSI of 74.7, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +6.7% compares to +20.4% for SPY (trailed the market by 13.7%).
$10,000 invested 1 year ago→ $10,669 today
vs. S&P 500 (SPY) — same period trailed market by 13.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($25.91)
✓Above 50-day MA ($25.17)
!RSI(14) neutral zone (30–70) — currently 74.7
✓Positive return (+6.7%)
✓Within 10% of period high (−6.8%)
Period Range $26.79
$23.58$28.75
RSI (14) 74.7
0 · OversoldOverbought · 100
Key Metrics
Price$26.79
Period Return+6.7%
Period High$28.75
Period Low$23.58
Drawdown−6.8%
MA-50$25.17
MA-200$25.91
RSI (14)74.7
Avg Volume (30d)40.4M
vs. SPYtrailed by 13.7%
Return Rank#614 of 1252
Trend Signals
Price is above the 200-day moving average ($25.91)